Chromosome Locations Flashcards
Wolf Hirschhorn
4p16.3
Cri-du-chat
5p15.3
Williams
7q11.23 (submicroscopic), can be missed by karyotype, need CMA
WAGR
Wilms, aniridia, GU, DD
11p13
Beckwith Wiedemann
11p15.5
KCNQOTI and H19
Prader Willi/Angelman
15q11.2-q13.1
Smith Magenis
17p11.2
Miller Dieker
17p13.3
NF1
17q11.2
Neurofibromin
Women increased risk of breast cancer and should have enhanced screening between 30-50 years
Sotos
5q35
NSD1
MLPA or FISH
macrocephaly, pointed chin, tall, obesity, DD, advanced bone age
sometimes seizures, psych, AOM, constipation, risk of tumors (~1%, no screen recommended)
Transient Neonatal DM
Paternal UPD 6
Imprinting 6q24
HYMAI, PLAGL1
Silver Russell
Maternal UPD 7
Imprinting 11p
Structural chromosome aberration
Hypomethylation of the paternal IC1 site on chromosome 11 explains about 45% of cases of Russell-Silver syndrome
macrocephaly, hypospadias, delayed bone age
BWS
Imprinting 11p
Paternal UPD 11p
Gene change, ex CDKN1C
Paternal duplication, inv, translocation
Gain of methylation or microdeletion of the maternal IC1 site of chromosome 11
Maternal UPD 14
SS, hypotonia, precocious puberty, truncal obesity, variable psychomotor retardation
Paternal UPD 14
Severe psychomotor retardation, polyhydramnios, finger contractures, bell shaped thorax with coat hanger sign ribs
PWS
Microdeletion (70%)
Maternal UPD 15 (25%)
Imprinting
Angelman
Microdeletion (70%)
Paternal UPD 15 (1-3%)
UBE3A mutation (5-10%)
Imprinting (3-5%)
Juvenile Polyposis Coli
BMPR1A
SMAD4 - also HHT
Peutz Jeghers
STK11
50% del
45% truncating
Risk of intussusception at any age!
Lifetime cancer risk 81%, mostly GI, CRC, esophageal, pancreatic
32% breast cancer risk
GREM1 Polyposis
5’ 40kb duplication
Mixed Polyposis with adentomatous, juvenile, and hyperplastic
Lynch
Also known as hereditary non Polyposis colon cancer (HNPCC)
CRC, endometrial, bile duct, ovarian, ureteral, and gliomas
PMS2, EPCAM, MSH2 and MLH1
Breast-Ovarian
BRCA1/2
BRCA2 < BRCA1 for ovarian
Cowden
PTEN syndromic features
Thyroid
Breast
Hereditary Breast Cancer
PALB2
CHEK2
ATM heterozygotes (colon, pancreatic, breast)
Breast+Gastric
CDH1
With or without cleft palate
Ovarian
RAD51C
BRCA2
Male breast cancer
Pancreatic
Prostate
Melanoma
Bloom
AR, BLM
SS, photosensitive skin, immunodeficiency
Leukemia, lymphoma, solid tumors
Werner
AR, WRN
Premature aging, cataracts, diabetes, atherosclerosis
Soft tissue sarcomas and skin cancers
DNA helicase defect (stop codon causing nonsense or frameshift)
NF2
Chromosome 22 for merlin
Schwannomatosis
Chromosome 22
SMARCB1 or LZTR1
Parkinson Disease
GBA1 - late onset
SNCA - alpha synuclein, AD
LRRK2 - onset >50, incomplete penetrance, AD
PRKN - early onset, AR
DNAJC6 - juvenile onset, DD, seizures, AR
TAF1 - XLR
DYT5
Dystonia, AD
DOPA responsive
Also DNAJC12 and SLC18A2
Huntington Repeats
General Population <26 repeats
Intermediate 27-35
HD = 36+
Reduced penetrance 36-39 repeats
CAG
Paternal inheritance in some cases is associated with the juvenile presentation of Huntington disease, with rigidity
Fragile X
CGG
200+ repeats
55-200 = can expand
80% have ADHD
GAA
Friedreich Ataxia
GAA expansions usually 90+, but in 300+ range
If one expansion and one normal, either a carrier or has the disease. To differentiate this, must point mutation analysis to confirm disease present.
CAG
HD
SCA
DRP atrophy
Spinal and bulbar atrophy
CTG
Myotonic dystrophy
Hereditary Spastic Paraplegia
AD: SPAST, ATLI, KIF5A, REEP1
AR: SPG11
XLR: L1CAM, PLP1
Myotonic Dystrophy
CTG repeat expansion in DMPK gene